Under-use of warfarin for patients with non-valvular atrial fibrillation in Japan

Internal Medicine

Volumn 43, Issue 7, 2004, Pages 529-530

  Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Anticoagulation; Atrial fibrillation; Embolism; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING DISORDER; CARDIOLOGY; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG USE; EDITORIAL; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HUMAN; JAPAN; MEDICAL SPECIALIST; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; TEACHING HOSPITAL; THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIOLOGY; CEREBROVASCULAR ACCIDENT; DRUG UTILIZATION; FEMALE; HOSPITALS, TEACHING; HUMANS; JAPAN; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; RISK ASSESSMENT; WARFARIN;

EID: 4444362791     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.529     Document Type: Editorial

References (13)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154; 1449-1457, 1994 (Erratum in: Arch Intern Med 154: 2254, 1994).
2. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 97: 1231-1233, 1998.
3. Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke 28: 2382-2389, 1997.
4. McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161: 2458-2463, 2001.
5. Johnston JA, Cluxton R Jr, Heaton PC, Guo JJ, Moomaw CJ, Eckman MH. Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med 163: 1705-1710, 2003.
6. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 155: 277-281, 1995.
7. Bradley BC, Perdue KS, Tisdel KA, Gilligan DM. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs Medical Center. Am J Cardiol 85: 568-572, 2000.
8. Research Group for Antiarrhythmic Drug Therapy. Survey of atrial fibrillation and thromboembolism in the elderly: A multicenter cooperative study. J Cardiol 33: 27-35, 1999 (Abstract in English).
9. Tomita F, Kohya T, Sakurai M, et al for the Hokkaido Atrial Fibrillation Study Group. Prevalence and clinical characteristics of patients with atrial fibrillation: Analysis of 20,000 cases in Japan. Jpn Circ J 64: 653-658, 2000.
10. Inoue H, Nozawa T, Okumura K, et al. Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse. Circ J 68: 417-421, 2004.
11. Cairns JA. Atrial Fibrillation: Antithrombotic therapy. in: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, Eds. Evidence-based Cardiology, London, BMJ Books, 1998: 544-552.
12. Inoue H, Atarashi H for the Research Group for Antiarrhythmic Drug Therapy. Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation. Am J Cardiol 86: 852-855, 2000.
13. Maeda K, Sakai T, Hira K, et al. Physicians' attitudes toward anticoagulation therapy in patients with chronic atrial fibrillation. Intern Med 43: 553-560, 2004.